# Hilde Rosing

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hilde-rosing/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,634 |
| Field | Cancer Treatment and Pharmacology |
| h-index | 65 |
| i10-index | 311 |
| Last Known Institution | Oncode Institute |
| OpenAlex ID | https://openalex.org/A5041259777 |
| ORCID iD | https://orcid.org/0000-0003-3124-692X |
| Works | 539 |

## Researcher papers

- [Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors](https://scholariq.org/papers/phase-i-and-pharmacokinetic-study-of-ecteinascidin-743-a-new-marine-compound/)

## Researcher topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Drug Transport and Resistance Mechanisms](https://scholariq.org/topics/drug-transport-and-resistance-mechanisms/)
- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)

## Researcher university

- [Oncode Institute](https://scholariq.org/institutions/oncode-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.